Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 1.91
IVC's Cash to Debt is ranked higher than
67% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 2.26 vs. IVC: 1.91 )
IVC' s 10-Year Cash to Debt Range
Min: 0.03   Max: 1.91
Current: 1.91

0.03
1.91
Equity to Asset 0.59
IVC's Equity to Asset is ranked higher than
66% of the 470 Companies
in the Global Medical Devices industry.

( Industry Median: 0.64 vs. IVC: 0.59 )
IVC' s 10-Year Equity to Asset Range
Min: 0.33   Max: 0.61
Current: 0.59

0.33
0.61
F-Score: 5
Z-Score: 2.70
M-Score: -3.00
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 4/10

vs
industry
vs
history
Operating margin (%) -4.56
IVC's Operating margin (%) is ranked higher than
64% of the 486 Companies
in the Global Medical Devices industry.

( Industry Median: 4.88 vs. IVC: -4.56 )
IVC' s 10-Year Operating margin (%) Range
Min: -4.78   Max: 10.8
Current: -4.56

-4.78
10.8
Net-margin (%) -4.38
IVC's Net-margin (%) is ranked higher than
64% of the 486 Companies
in the Global Medical Devices industry.

( Industry Median: 2.74 vs. IVC: -4.38 )
IVC' s 10-Year Net-margin (%) Range
Min: -21.21   Max: 6.39
Current: -4.38

-21.21
6.39
ROE (%) -8.91
IVC's ROE (%) is ranked higher than
62% of the 477 Companies
in the Global Medical Devices industry.

( Industry Median: 3.43 vs. IVC: -8.91 )
IVC' s 10-Year ROE (%) Range
Min: -51.33   Max: 17.92
Current: -8.91

-51.33
17.92
ROA (%) -5.33
IVC's ROA (%) is ranked higher than
64% of the 513 Companies
in the Global Medical Devices industry.

( Industry Median: 0.95 vs. IVC: -5.33 )
IVC' s 10-Year ROA (%) Range
Min: -20.26   Max: 8.47
Current: -5.33

-20.26
8.47
ROC (Joel Greenblatt) (%) -28.35
IVC's ROC (Joel Greenblatt) (%) is ranked higher than
62% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 5.54 vs. IVC: -28.35 )
IVC' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -31.39   Max: 54.75
Current: -28.35

-31.39
54.75
Revenue Growth (3Y)(%) -10.80
IVC's Revenue Growth (3Y)(%) is ranked higher than
57% of the 347 Companies
in the Global Medical Devices industry.

( Industry Median: 4.20 vs. IVC: -10.80 )
IVC' s 10-Year Revenue Growth (3Y)(%) Range
Min: -10.8   Max: 17.3
Current: -10.8

-10.8
17.3
EPS Growth (3Y)(%) 54.80
IVC's EPS Growth (3Y)(%) is ranked higher than
97% of the 314 Companies
in the Global Medical Devices industry.

( Industry Median: -1.70 vs. IVC: 54.80 )
IVC' s 10-Year EPS Growth (3Y)(%) Range
Min: -74.2   Max: 239.1
Current: 54.8

-74.2
239.1
» IVC's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2014

IVC Guru Trades in Q1 2014

Paul Tudor Jones 12,300 sh (New)
Richard Snow Sold Out
Chuck Royce 1,329,161 sh (-8.70%)
Jim Simons 243,693 sh (-38.04%)
» More
Q2 2014

IVC Guru Trades in Q2 2014

HOTCHKIS & WILEY 1,243,400 sh (New)
Chuck Royce 1,689,436 sh (+27.11%)
Paul Tudor Jones Sold Out
Jim Simons 87,000 sh (-64.30%)
» More
Q3 2014

IVC Guru Trades in Q3 2014

HOTCHKIS & WILEY 2,173,400 sh (+74.79%)
Jim Simons Sold Out
Chuck Royce 1,680,036 sh (-0.56%)
» More
Q4 2014

IVC Guru Trades in Q4 2014

Charles Brandes 65,985 sh (New)
HOTCHKIS & WILEY 2,162,700 sh (unchged)
HOTCHKIS & WILEY 2,162,700 sh (-0.49%)
Chuck Royce 1,535,742 sh (-8.59%)
» More
» Details

Insider Trades

Latest Guru Trades with IVC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 1.10
IVC's P/B is ranked higher than
92% of the 576 Companies
in the Global Medical Devices industry.

( Industry Median: 4.48 vs. IVC: 1.10 )
IVC' s 10-Year P/B Range
Min: 0.55   Max: 2.36
Current: 1.1

0.55
2.36
P/S 0.50
IVC's P/S is ranked higher than
96% of the 576 Companies
in the Global Medical Devices industry.

( Industry Median: 4.21 vs. IVC: 0.50 )
IVC' s 10-Year P/S Range
Min: 0.23   Max: 1.21
Current: 0.5

0.23
1.21
POCF 69.82
IVC's POCF is ranked higher than
77% of the 576 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. IVC: 69.82 )
IVC' s 10-Year POCF Range
Min: 3.84   Max: 78.26
Current: 69.82

3.84
78.26
EV-to-EBIT -10.37
IVC's EV-to-EBIT is ranked higher than
69% of the 576 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. IVC: -10.37 )
IVC' s 10-Year EV-to-EBIT Range
Min: -150.5   Max: 168
Current: -10.37

-150.5
168
Shiller P/E 83.00
IVC's Shiller P/E is ranked higher than
78% of the 576 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. IVC: 83.00 )
IVC' s 10-Year Shiller P/E Range
Min: 10.78   Max: 84.21
Current: 83

10.78
84.21
Current Ratio 1.36
IVC's Current Ratio is ranked higher than
50% of the 505 Companies
in the Global Medical Devices industry.

( Industry Median: 2.67 vs. IVC: 1.36 )
IVC' s 10-Year Current Ratio Range
Min: 1.36   Max: 2.65
Current: 1.36

1.36
2.65
Quick Ratio 0.83
IVC's Quick Ratio is ranked lower than
52% of the 505 Companies
in the Global Medical Devices industry.

( Industry Median: 1.98 vs. IVC: 0.83 )
IVC' s 10-Year Quick Ratio Range
Min: 0.83   Max: 1.9
Current: 0.83

0.83
1.9
Days Inventory 63.37
IVC's Days Inventory is ranked higher than
93% of the 576 Companies
in the Global Medical Devices industry.

( Industry Median: 174.47 vs. IVC: 63.37 )
IVC' s 10-Year Days Inventory Range
Min: 50.69   Max: 67.9
Current: 63.37

50.69
67.9
Days Sales Outstanding 45.78
IVC's Days Sales Outstanding is ranked higher than
91% of the 576 Companies
in the Global Medical Devices industry.

( Industry Median: 83.34 vs. IVC: 45.78 )
IVC' s 10-Year Days Sales Outstanding Range
Min: 46.1   Max: 104.19
Current: 45.78

46.1
104.19

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.30
IVC's Dividend Yield is ranked lower than
92% of the 189 Companies
in the Global Medical Devices industry.

( Industry Median: 1.44 vs. IVC: 0.30 )
IVC' s 10-Year Dividend Yield Range
Min: 0.1   Max: 0.46
Current: 0.3

0.1
0.46
Yield on cost (5-Year) 0.30
IVC's Yield on cost (5-Year) is ranked lower than
88% of the 191 Companies
in the Global Medical Devices industry.

( Industry Median: 1.47 vs. IVC: 0.30 )
IVC' s 10-Year Yield on cost (5-Year) Range
Min: 0.1   Max: 0.46
Current: 0.3

0.1
0.46
Share Buyback Rate 0.20
IVC's Share Buyback Rate is ranked higher than
88% of the 333 Companies
in the Global Medical Devices industry.

( Industry Median: -1.40 vs. IVC: 0.20 )
IVC' s 10-Year Share Buyback Rate Range
Min: 1.3   Max: -1.2
Current: 0.2

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 6.20
IVC's Price/Tangible Book is ranked higher than
65% of the 576 Companies
in the Global Medical Devices industry.

( Industry Median: 8.40 vs. IVC: 6.20 )
IVC' s 10-Year Price/Tangible Book Range
Min: 3.31   Max: 94.61
Current: 6.2

3.31
94.61
Price/DCF (Projected) 0.60
IVC's Price/DCF (Projected) is ranked higher than
99% of the 576 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. IVC: 0.60 )
IVC' s 10-Year Price/DCF (Projected) Range
Min: 0.39   Max: 1.82
Current: 0.6

0.39
1.82
Price/Median PS Value 1.10
IVC's Price/Median PS Value is ranked higher than
79% of the 576 Companies
in the Global Medical Devices industry.

( Industry Median: 1.40 vs. IVC: 1.10 )
IVC' s 10-Year Price/Median PS Value Range
Min: 0.6   Max: 3.27
Current: 1.1

0.6
3.27
Earnings Yield (Greenblatt) -9.60
IVC's Earnings Yield (Greenblatt) is ranked lower than
51% of the 492 Companies
in the Global Medical Devices industry.

( Industry Median: 1.40 vs. IVC: -9.60 )
IVC' s 10-Year Earnings Yield (Greenblatt) Range
Min: -9.6   Max: 10.8
Current: -9.6

-9.6
10.8
Forward Rate of Return (Yacktman) -17.76
IVC's Forward Rate of Return (Yacktman) is ranked higher than
59% of the 212 Companies
in the Global Medical Devices industry.

( Industry Median: 3.42 vs. IVC: -17.76 )
IVC' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -15.1   Max: 20.4
Current: -17.76

-15.1
20.4

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Traded in other countries:IV3.Germany,
Invacare Corp was incorporated in 1971. The Company manufactures and distributes in various markets for medical equipment used in the home and long-term care settings based upon its distribution channels, breadth of product line and net sales. It also designs, manufactures and distributes an extensive line of health care products for the non-acute care environment, including the home health care and extended care markets. The Company sells its products to home health care and medical equipment providers, distributors and government locations in the United States, Europe, Canada, New Zealand, Australia and Asia. Its products are sold through the distribution network by its sales force, telesales associates and independent manufacturers' representatives and distributors. The Company operates in four primary business segments; North America/Home Medical Equipment or North America/HME, Institutional Products Group (IPG), Europe and Asia/Pacific. The North America/HME segment sells each of three primary product lines, which includes; lifestyle, mobility and seating and respiratory therapy products. IPG sells or rents long-term care medical equipment, health care furnishings and accessory products. Europe and Asia/Pacific sell product lines similar to North America/HME and IPG. Each business segment sells to the home health care, retail and extended care markets. The Company purchases raw materials, fabricated components, some finished goods and services from a variety of suppliers. Raw materials such as plastics, steel and aluminum are considered key raw materials. The Company's North America/HME sales and marketing organization consists primarily of a sales force which markets and sells Invacare branded products to HME providers. It also holds patent and other intellectual property licenses from third parties for some of its products and on technologies that are necessary in the design and manufacture of some of the Company's products. The Company is directly affected by government regulation and reimbursement policies in virtually every country in which the Company operates.
» More Articles for IVC

Headlines

Articles On GuruFocus.com
Invacare Corporation: Sell First, Ask Questions Later? Feb 15 2012 
Invacare Corp. Reports Operating Results (10-K) Feb 25 2011 
Invacare Corp. Reports Operating Results (10-Q) Nov 05 2010 
Invacare Corp. Reports Operating Results (10-Q) Aug 06 2010 
Invacare Corp. Reports Operating Results (10-Q) May 06 2010 
Invacare Corp. Reports Operating Results (10-Q) Nov 05 2009 
Invacare Corp. Reports Operating Results (10-Q) May 07 2009 
Invacare Corporation Reports Earnings within Guidance and Strong Free Cash Flow Jan 29 2009 
Invacare Corporation to Host Conference Call to Discuss Q4 2008 Results Jan 20 2009 
Weekly CEO Buys Highlight: American Water Works Company, Inc., CocaCola Enterprises Inc., SAVVIS Inc May 07 2008 

More From Other Websites
Invacare Corporation to Host Conference Call to Discuss First Quarter 2015 Financial Results Apr 15 2015
Invacare Corporation to Host Conference Call to Discuss First Quarter 2015 Financial Results Apr 14 2015
Invacare Cut to Strong Sell on Dismal Q4, Should You Dump? - Analyst Blog Mar 12 2015
Invacare Interim President and Chief Executive Officer Presenting at Sidoti & Company, LLC... Mar 06 2015
INVACARE CORP Financials Mar 05 2015
10-K for Invacare Corp. Feb 28 2015
INVACARE CORP Files SEC form 10-K, Annual Report Feb 26 2015
CORRECTING and REPLACING Invacare Declares Quarterly Dividend Feb 13 2015
CORRECTING and REPLACING Invacare Declares Quarterly Dividend Feb 13 2015
Invacare Declares Quarterly Dividend Feb 13 2015
Invacare (IVC) Crumbles: Stock Falls by 6% - Tale of the Tape Feb 09 2015
Invacare (IVC) Reports Narrower Q4 Loss, Beats on Revenues - Analyst Blog Feb 06 2015
INVACARE CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Feb 05 2015
Q4 2014 Invacare Corp Earnings Release - Before Market Open Feb 05 2015
Invacare reports 4Q loss Feb 05 2015
Invacare reports 4Q loss Feb 05 2015
Invacare Corporation Announces Financial Results for the Quarter and Year Ended December 31, 2014 Feb 05 2015
Invacare Corporation Announces Financial Results for the Quarter and Year Ended December 31, 2014 Feb 05 2015
INVACARE CORP Files SEC form 8-K, Change in Directors or Principal Officers Feb 02 2015
INVACARE CORP Files SEC form 8-K, Change in Directors or Principal Officers Jan 22 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK